Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of PERT on Postoperative Complications and Physiological Status in Patients Undergoing Pancreaticoduodenectomy

NCT06119880 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT06119880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06119880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of PERT on Postoperative Complications and Physiological Status in Patients Undergoing Pancreaticoduodenectomy
Lead sponsor
Ruijin Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 1, 2023
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic enzyme replacement therapy, pancreatic exocrine insufficiency, pancreaticoduodenectomy